Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Amrish Patel

Pain Medicine McDonough, GA Medical Doctor

NPI 1871755025 CMS profile 130838

2340 Patrick Henry Pkwy, Suite 150, McDonough, GA 30253

Open in the dashboard

General payments

$8,583

174 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Amrish Patel of McDonough, GA is reported in the CMS Open Payments database as having received $8,583 across 174 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $18 1
2023 General $151 8
2022 General $984 28
2021 General $948 40
2020 General $553 30
2019 General $5,928 67

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amrish Patel
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Amrish Patel were reported at $0. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.

Show as a table
Year Amrish Patel Pain Medicine median Middle half National median
2019 $5,928 $409 $115–$1,311 $163
2020 $553 $214 $66–$666 $114
2021 $948 $299 $84–$899 $132
2022 $984 $335 $103–$1,149 $149
2023 $151 $376 $114–$1,228 $160
2024 $18 $387 $115–$1,173 $164
2025 $0 $402 $130–$1,173 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Medtronic Vascular, Inc. $4,636 2 payments
  2. SI-BONE, Inc. $627 6 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $492 31 payments
  4. Collegium Pharmaceutical, Inc. $401 24 payments
  5. ASSERTIO THERAPEUTICS, Inc. $361 27 payments
  6. Horizon Therapeutics plc $255 19 payments
  7. Nevro Corp. $243 1 payment
  8. Medtronic, Inc. $168 1 payment
  9. Abbott Laboratories $150 2 payments
  10. Ferring Pharmaceuticals Inc. $132 7 payments
  11. Other $1,119 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Royalty or License $4,499 1 payment
  2. Food and Beverage $4,074 172 payments
  3. Education $10 1 payment
Products named General payments · program years 2019–2024
  1. VenaSeal $4,499 1 payment
  2. IFUSE IMPLANT $386 4 payments
  3. Zipsor $348 26 payments
  4. Cambia $348 26 payments
  5. Gralise $348 26 payments
  6. XTAMPZA $344 21 payments
  7. RELISTOR Gastroenterology $285 16 payments
  8. RELISTOR Gastroenterology $253 21 payments
  9. Omnia $243 1 payment
  10. PENNSAID $191 14 payments
  11. Other $2,341 101 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

174 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record